Lipidomics studies on macrophages - RAW 264.7 cells treated with Kdo2-Lipid A and compactin

Introduction | Browse | Search | Download
Mouse-over the above links for more information

Treatment details

LM ID Analyte Treatment Time(hrs) Sample ID Value Units
LMFA03080002 5,6-EET cPLA2i 1.0 BCD110605C28 1.39 pmol/ml medium
LMFA03080002 5,6-EET cPLA2i 1.0 BCD110605C30 1.53 pmol/ml medium
LMFA03080002 5,6-EET cPLA2i 1.0 BCD110605C29 1.79 pmol/ml medium
LMFA03080002 5,6-EET cPLA2i 20.0 BCD110605C64 6.36 pmol/ml medium
LMFA03080002 5,6-EET cPLA2i 20.0 BCD110605C66 6.77 pmol/ml medium
LMFA03080002 5,6-EET cPLA2i 20.0 BCD110605C65 5.93 pmol/ml medium
LMFA03080002 5,6-EET PLDi 1.0 BCD110605C16 1.68 pmol/ml medium
LMFA03080002 5,6-EET PLDi 1.0 BCD110605C17 1.88 pmol/ml medium
LMFA03080002 5,6-EET PLDi 1.0 BCD110605C18 1.5 pmol/ml medium
LMFA03080002 5,6-EET PLDi 20.0 BCD110605C54 7.81 pmol/ml medium
LMFA03080002 5,6-EET PLDi 20.0 BCD110605C52 9.97 pmol/ml medium
LMFA03080002 5,6-EET PLDi 20.0 BCD110605C53 9.83 pmol/ml medium
LMFA03080002 5,6-EET KDO+cPLA2i 1.0 BCD110605C32 1.23 pmol/ml medium
LMFA03080002 5,6-EET KDO+cPLA2i 1.0 BCD110605C31 1.66 pmol/ml medium
LMFA03080002 5,6-EET KDO+cPLA2i 1.0 BCD110605C33 1.3 pmol/ml medium
LMFA03080002 5,6-EET KDO+cPLA2i 20.0 BCD110605C68 4.41 pmol/ml medium
LMFA03080002 5,6-EET KDO+cPLA2i 20.0 BCD110605C69 4.46 pmol/ml medium
LMFA03080002 5,6-EET KDO+cPLA2i 20.0 BCD110605C67 3.98 pmol/ml medium
LMFA03080002 5,6-EET KDO+PLDi 1.0 BCD110605C19 1.6 pmol/ml medium
LMFA03080002 5,6-EET KDO+PLDi 1.0 BCD110605C20 1.61 pmol/ml medium
LMFA03080002 5,6-EET KDO+PLDi 1.0 BCD110605C21 1.44 pmol/ml medium
LMFA03080002 5,6-EET KDO+PLDi 20.0 BCD110605C56 4.87 pmol/ml medium
LMFA03080002 5,6-EET KDO+PLDi 20.0 BCD110605C57 5.76 pmol/ml medium
LMFA03080002 5,6-EET KDO+PLDi 20.0 BCD110605C55 5.59 pmol/ml medium
LMFA03080002 5,6-EET KDO+ATP+cPLA2i 1.0 BCD110605C37 1.38 pmol/ml medium
LMFA03080002 5,6-EET KDO+ATP+cPLA2i 1.0 BCD110605C38 1.19 pmol/ml medium
LMFA03080002 5,6-EET KDO+ATP+cPLA2i 1.0 BCD110605C39 1.45 pmol/ml medium
LMFA03080002 5,6-EET KDO+ATP+cPLA2i 20.0 BCD110605C74 1.69 pmol/ml medium
LMFA03080002 5,6-EET KDO+ATP+cPLA2i 20.0 BCD110605C75 1.77 pmol/ml medium
LMFA03080002 5,6-EET KDO+ATP+cPLA2i 20.0 BCD110605C73 2.17 pmol/ml medium
LMFA03080002 5,6-EET KDO+ATP+PLDi 1.0 BCD110605C25 2.13 pmol/ml medium
LMFA03080002 5,6-EET KDO+ATP+PLDi 1.0 BCD110605C27 1.98 pmol/ml medium
LMFA03080002 5,6-EET KDO+ATP+PLDi 1.0 BCD110605C26 1.69 pmol/ml medium
LMFA03080002 5,6-EET KDO+ATP+PLDi 20.0 BCD110605C61 2.43 pmol/ml medium
LMFA03080002 5,6-EET KDO+ATP+PLDi 20.0 BCD110605C62 2.37 pmol/ml medium
LMFA03080002 5,6-EET KDO+ATP+PLDi 20.0 BCD110605C63 1.98 pmol/ml medium
LMFA03080002 5,6-EET KDO + ATP 1.0 BCD110605C15 1.8 pmol/ml medium
LMFA03080002 5,6-EET KDO + ATP 1.0 BCD110605C14 1.93 pmol/ml medium
LMFA03080002 5,6-EET KDO + ATP 1.0 BCD110605C13 1.45 pmol/ml medium
LMFA03080002 5,6-EET KDO + ATP 20.0 BCD110605C49 2.98 pmol/ml medium
LMFA03080002 5,6-EET KDO + ATP 20.0 BCD110605C50 2.81 pmol/ml medium
LMFA03080002 5,6-EET KDO + ATP 20.0 BCD110605C51 2.5 pmol/ml medium
LMFA03080002 5,6-EET KDO 1.0 BCD110605C08 1.81 pmol/ml medium
LMFA03080002 5,6-EET KDO 1.0 BCD110605C07 1.5 pmol/ml medium
LMFA03080002 5,6-EET KDO 1.0 BCD110605C09 1.56 pmol/ml medium
LMFA03080002 5,6-EET KDO 20.0 BCD110605C45 7.71 pmol/ml medium
LMFA03080002 5,6-EET KDO 20.0 BCD110605C44 6.89 pmol/ml medium
LMFA03080002 5,6-EET KDO 20.0 BCD110605C43 7.48 pmol/ml medium
LMFA03080002 5,6-EET C 0.0 BCD110605C03 1.81 pmol/ml medium
LMFA03080002 5,6-EET C 0.0 BCD110605C01 2.06 pmol/ml medium